ASIA unversity:Item 310904400/111908
English  |  正體中文  |  简体中文  |  Items with full text/Total items : 92958/108462 (86%)
Visitors : 20419520      Online Users : 229
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version

    Please use this identifier to cite or link to this item:

    Title: Eriobotrya japonica ameliorates cardiac hypertrophy in H9c2 cardiomyob last and in spontaneo usly hypertensive rats
    Authors: Chi, Jui-Ting
    Chiang, Jui-Ting
    Farheen, Khan
    Badrealam, Khan Farheen
    Marthandam, A
    Shibu, Marthandam Asokan
    Kuo, Chia-Hua
    Kuo, Chia-Hua
    Hu, Chih-Yang
    Huang, Chih-Yang
    Ch, Bih-Cheng
    Chen, Bih-Cheng
    Lin, Yueh-Min
    Lin, Yueh-Min
    Padma, Vijaya
    Viswanadha, Vijaya Padma
    Kuo, Wei-Wen
    Kuo, Wei-Wen
    Contributors: 生物科技學系
    Date: 2018-11
    Issue Date: 2019-09-02 14:35:17 (UTC+8)
    Abstract: Eriobotrya japonica (EJ) is a traditional Chinese plant with high medicinal value. EJ extracts are reported to exhibit antioxidant and anti-inflammatory biological attributes. The current study aims to evaluate the prospective efficacy of E. japonica leave extract (EJLE) against Angiotensin-II induced cardiac hypertrophy in H9c2 cardiomyoblast and in spontaneously hypertensive rats (SHRs). For the in vitro studies, Angiotensin-II pretreated H9c2 cells were treated with EJLE and analyzed through Western blotting and rhodamine phalloidin staining for their cardio-protective attributes. In the in vivo studies, 12-week-old SHRs were randomly divided into groups: SHRs supplemented with EJLE, control SHR group supplemented with PBS; in addition, a control group of Wistar-Kyoto rats (WKY) was also employed. All rats were supplemented twice a week for 8 week time interval. Finally, echocardiography, morphological, histology, and Western blot analysis were performed to assess their role against cardiac hypertrophy. Interestingly, we could observe that supplementation of EJLE could rescue Ang-II induced cardiac hypertrophy as evident through Western blot, rhodamine phalloidin staining, and Hematoxylin-Eosin staining. Notably, morphological and echocardiography data provided further supports for their ability to ameliorate cardiac characteristics. Cumulatively, the results clearly suggests that supplementation of EJLE promotes cardio-protective effects through amelioration of cardiac hypertrophy in vitro and in vivo.
    Appears in Collections:[Department of Biotechnology] Journal Article

    Files in This Item:

    There are no files associated with this item.

    All items in ASIAIR are protected by copyright, with all rights reserved.

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback